Initial differentiation of the metanephric mesenchyme is independent of WT1 and the ureteric bud

Developmental Genetics

Volumn 24, Issue 3-4, 1999, Pages 252-262

  Donovan, Michael J ^a,e   Natoli, Thomas A ^a,d   Sainio, Kirsi ^b   Amstutz, Alice ^a   Jaenisch, Rudolf ^c   Sariola, Hannu ^b   Kreidberg, Jordan A ^a,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e MILLENNIUM PHARMACEUTICALS INC   (United States)

Author keywords

GDNF; Kidney; Pax 2; Six 2; WT1

Indexed keywords

GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; RNA;

ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STRUCTURES; KIDNEY DEVELOPMENT; MESENCHYME CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DIFFERENTIATION; TUMOR SUPPRESSOR GENE; URETER;

ANIMALS; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENES, WILMS TUMOR; IN SITU HYBRIDIZATION; KIDNEY; MESODERM; MICE; MICE, KNOCKOUT; ORGAN CULTURE TECHNIQUES; URETER;

ANIMALIA; WOLFFIA;

EID: 0032900981     PISSN: 0192253X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6408(1999)24:3/4<252::AID-DVG8>3.0.CO;2-K     Document Type: Article

References (53)

1. Armstrong JF, Pritchard-Jones K, Bickmore WA, Hastie ND, Bard JB. 1993. The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo. Mech Dev 40:85-97.
2. Bard JBL, Ross ASA. 1991. LIF, the ES-cell inhibition factor, reversibly blocks nephrogenesis in cultured mouse kidney rudiments. Development 113:193-198.
3. Bard JBL, McConnell JE, Davies JA. 1994. Towards a genetic basis for kidney development. Mech Dev 48:3-11.
4. Buckler AJ, Pelletier J, Haber DA, Glaser T, Housman DE. 1991. Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development. Mol Cell Biol 11:1707-1712.
5. Bullock SL, Fletcher JM, Beddington RSP, Wilson VA. 1998. Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. Genes and Development 12:1894-1906.
6. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE. 1990. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms'tumor locus. Cell 60:509-520.
7. Caricasole A, Duarte A, Larsson SH, Hastie ND, Little M, Holmes G, Todorov I, Ward A. 1996. RNA binding by the Wilms tumor suppressor zinc finger proteins. Proc Natl Acad Sci USA 93:7562-7566.
8. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
9. Cook DM, Hinkes MT, Bernfield M, Rauscher FJ III. 1996. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1. Oncogene 13:1789-1799.
10. Dey BR, Sukhatme VP, Roberts AB, Sporn MB, Rauscher FR, Kim SJ. 1994. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product. Mol Endocrinol 8:595-602.
11. Dressler GR, Douglass EC. 1992. Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. Proc Natl Acad Sci USA 89:1179-1183.
12. Dressler GR, Deutsch U, Chowdhury K, Nornes HO, Gruss P. 1990. Pax2, a new murine paired-box-containing gene and its expression in the developing excretory system. Development 109:787-795.
13. Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FD. 1992. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. Science 257:674-678.
14. Drummond IA, Rupprecht HD, Rohwer-Nutter P, Lopez-Guisa JM, Madden SL, Rauscher FR, Sukhatme VP. 1994. DNA recognition by splicing variants of the Wilms' tumor suppressor, WT1. Mol Cell Biol 14:3800-3809.
15. Englert C, Hou X, Maheswaran S, Bennett P, Ngwu C, Re GG, Garvin AJ, Rosner MR, Haber DA. 1995. WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis. EMBO J 14:4662-4675.
16. Friedrich G, Soriano P. 1991. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev 5:1513-1523.
17. Gashler AL, Bonthron DT, Madden SL, Rauscher FD, Collins T, Sukhatme VP. 1992. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. Proc Natl Acad Sci USA 89:10984-10988.
18. Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GA. 1990. Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 343:774-778.
19. Grobstein C. 1953. Inductive epithelio-mesenchymal interaction in the cultured organ rudiments of the mouse. Science 118:52-55.
20. Grobstein C. 1955. Inductive interactions in the development of the mouse metanephros. J Exp Zool 130:319-340.
21. Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE. 1991. Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA 88:9618-9622.
22. Hamilton TB, Barilla KC, Romaniuk PJ. 1995. High affinity binding sites for the Wilms' tumor suppressor protein WT1. Nucleic Acids Res 23:277-284.
23. Jing S, Wen D, Yu Y, Hoist PL, Luo Y, Fang M, Tamir R, Antonio L, Hu Z, Cupples R, Louis JC, Hu S, Altrock BW, Fox GM. 1996. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85:1113-1124.
24. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R. 1993. WT-1 is required for early kidney development. Cell 74:679-691.
25. Kudoh T, Ishidate T, Moriyama M, Toyoshima K, Akiyama T. 1995. G1 phase arrest induced by Wilms tumor protein WT-1 is abrogated by cyclin/CDK complexes. Proc Natl Acad Sci USA 92:4517-4521.
26. Larsson S, Charlieu J-P, Miyagawa K, Engelkamp D, Rassoulzaegan M, Ross A, Cuzin F, van Heyningen V, Hastie ND. 1995. Subnuclear localization of WT-1 in splicing or transcription factor domains is regulated by alternative splicing. Cell 81:391-401.
27. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F. 1993. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132.
28. Miyamoto N, Yoshida M, Kuratani S, Matsuo I, Aizawa S. 1997. Defects of urogenital development in mice lacking Emx2. Development 124:1653-1664.
29. Moore MW, Klein RD, Farinas I, Sauer H, Armani M, Philips H, Reichardt LF, Ryan AM, Carver-Moore K, Rosenthal A. 1996. Renal and neuronal abnormalities in mice lacking GDNF. Nature 382: 76-79.
30. Muller U, Wang D, Denda S, Meneses JJ, Pedersen RA, Reichardt LF. 1997. Integrin alpha8beta 1 is critically important for epithelial-mesenchymal interactions during kidney morphogenesis. Cell 88: 603-613.
31. Nakagama H, Heinrich G, Pelletier J, Housman DE. 1995. Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product. Mol Cell Biol 15:1489-1498.
32. Oliver G, Wehr R, Jenkins NA, Copeland NG, Cheyette BN, Hartenstein V, Zipursky SL, Gruss P. 1995. Homeobox genes and connective tissue patterning. Development 121:693-705.
33. Pelletier J, Schalling M, Buckler AJ, Rogers A, Haber DA, Housman D. 1991. Expression of the Wilms' tumor gene WT1 in the murine urogenital system. Genes Dev 5:1345-1356.
34. Pichel JG, Shen L, Sheng HZ, Granholm A-C, Drago J, Grinberg A, Lee EJ, Huang SP, Saarma M, Hoffer BJ, Sariola H, Westphal H. 1996. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 382:73-76.
35. Rauscher FD, Morris JF, Tournay OE, Cook DM, Curran T. 1990. Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. Science 250:1259-1262.
36. Rupprecht HD, Drummond IA, Madden SL, Rauscher FR, Sukhatme VP. 1994. The Wilms' tumor suppressor gene WT1 is negatively autoregulated. J Biol Chem 269:6198-6206.
37. Ryan G, Steele PV, Morris JF, Rauscher FR, Dressler GR. 1995. Repression of Pax-2 by WT1 during normal kidney development. Development 121:867-875.
38. Sainio K, Hellstedt P, Kreidberg JA, Saxen L, Sariola H. 1997a. Differential regulation of two sets of mesonephric tubules by WT-1. Development 124:1293-1299.
39. Sainio K, Suvanto P, Davies J, Wartiovaara J, Wartiovaara K, Saarma M, Arumae U, Meng X, Lindahl M, Pachnis V, Sariola H. 1997b. Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium. Development 124:4077-4087.
40. Sanchez MP, Silos-Santiago I, Frisen J, He B, Lira SA, Barbacid M. 1996. Renal aegenesis and absence of enteric ganglions in mice lacking GDNF. Nature 382:70-74.
41. Sanes JR, Rubenstein JL, Nicolas JF. 1986. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos. EMBO J 5:3133-3142.
42. Sanicola M, Hession C, Worley D, Carmillo P, Ehrenfels C, Walus L, Robinson S, Jaworski G, Wei H, Tizard R, Whitty A, Pepinsky RB, Gate RL. 1997. Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins. Proc Natl Acad Sci USA 94:6238-6243.
43. Saxen L. 1987. Organogenesis of the kidney. Cambridge, UK: Cambridge University Press.
44. Saxen L, Lehtonen E. 1987. Embryonic kidney in organ culture. Differentiation 36:2-11.
45. Schuchardt A, D'Agati V, Larsson BL, Costantini F, Pachnis V. 1994. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret [see comments]. Nature 367:380-383.
46. Torres M, Gomez PE, Dressler GR, Gruss P. 1995. Pax-2 controls multiple steps of urogenital development. Development 121:4057-4065.
47. Treanor JJ, Goodman L, de SF, Stone DM, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, Phillips HS, Goddard A, Moore MW, Buj BA, Davies AM, Asai N, Takahashi M, Vandlen R, Henderson CE, Rosenthal A. 1996. Characterization of a multicomponent receptor for GDNF [see comments]. Nature 382:80-83.
48. Trupp M, Arenas E, Fainzilber M, Nilsson A-S, Sieber BA, Grigoriou M, Kilkenny C, Salazar-Grueso E, Pachnis V, Arumae U, Sariola H, Saarma M, Ibanez CF. 1996. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381:785-789.
49. van Heyningen V, Bickmore WA, Seawright A, Fletcher JM, Maule J, Fekete G, Gessler M, Bruns GA, Huerre-Jeanpierre C, Junien C, et al. 1990. Role for the Wilms tumor gene in genital development? Proc Natl Acad Sci USA 87:5383-5386.
50. Wang ZY, Madden SL, Deuel TF, Rauscher FD. 1992. The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. J Biol Chem 267:21999-22002.
51. Werner H, Re GG, Drummond IA, Sukhatme VP, Rauscher FD, Sens DA, Garvin AJ, Le Roith D, Roberts C Jr. 1993. Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product. Proc Natl Acad Sci USA 90:5828-5832.
52. Werner H, Rauscher FR, Sukhatme VP, Drummond IA, Roberts C Jr, Le Roith D. 1994. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site. J Biol Chem 269:12577-12582.
53. Wilkinson DG, Nieto MA. 1993. Detection of messenger RNAby in situ hybridization to tissue sections and whole mounts. In: Wassarman PM, DePamphilis ML, editors. Guide to techniques in mouse development. Vol. 225. San Diego: Academic Press.